SLC2A1 and cancer: Of note, the pharmacological blockade of glucose uptake by GLUT inhibitors was proved to exert cancer killing effects by the promoting disulfidptosis in SLC7A11-high tumor cells, highlighting the therapeutic utility of disulfidptosis-induction strategies in cancer treatment10.